While GLP-1s were never designed specifically for bones and joints, the effects they have on the musculoskeletal system are proving to be significantand potentially life-changing
Advertisement Article continues below this ad A Kaiser Family Fund survey released in November showed that one out of eight Americans, or 12% of survey respondents, are currently taking a GLP-1, and one out of five, or 18%, have tried one in the past
For information on recommended timing of when to stop GLP1-RAs prior to pregnancy please see Glucagon-like peptide-1 receptor agonists during pregnancy and lactation
We recommend checking out this guide for some tips on how to safely inject semaglutide
Commercial Member Health Plan Study
Managing Side Effects in Combined Protocols Combining multiple peptides with Retatrutide creates potential for both additive benefits and compounded side effects